Predictive factors requiring high-dose evocalcet in hemodialysis patients with secondary hyperparathyroidism. Tokumoto M, Tokunaga S, Asada S, Endo Y, et al. PLoS One 2022;17:e0279078.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tokumoto M, Tokunaga S, Asada S, Endo Y, et al. Predictive factors requiring high-dose evocalcet in hemodialysis patients with secondary hyperparathyroidism. PLoS One 2022;17:e0279078.
PMID: 36512619